244 related articles for article (PubMed ID: 18166168)
21. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid.
Lagoa R; Lopez-Sanchez C; Samhan-Arias AK; Gañan CM; Garcia-Martinez V; Gutierrez-Merino C
J Neurochem; 2009 Oct; 111(2):473-87. PubMed ID: 19682208
[TBL] [Abstract][Full Text] [Related]
22. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
[TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
Giampà C; Patassini S; Borreca A; Laurenti D; Marullo F; Bernardi G; Menniti FS; Fusco FR
Neurobiol Dis; 2009 Jun; 34(3):450-6. PubMed ID: 19281846
[TBL] [Abstract][Full Text] [Related]
24. NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease.
Napolitano M; Zei D; Centonze D; Palermo R; Bernardi G; Vacca A; Calabresi P; Gulino A
Neurosci Lett; 2008 Apr; 434(3):241-6. PubMed ID: 18329171
[TBL] [Abstract][Full Text] [Related]
25. Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid.
Blum D; Hemming FJ; Galas MC; Torch S; Cuvelier L; Schiffmann SN; Sadoul R
Neurosci Lett; 2004 Sep; 368(3):309-13. PubMed ID: 15364417
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y
Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway.
Li Y; Wu J; Shou Z; He Q; Zhang P; Han F; Li H; Chen J
Nephrology (Carlton); 2008 Dec; 13(6):508-16. PubMed ID: 18331437
[TBL] [Abstract][Full Text] [Related]
29. 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions.
Mirandola SR; Melo DR; Saito A; Castilho RF
J Neurosci Res; 2010 Feb; 88(3):630-9. PubMed ID: 19795369
[TBL] [Abstract][Full Text] [Related]
30. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease.
Dalbem A; Silveira CV; Pedroso MF; Breda RV; Werne Baes CV; Bartmann AP; da Costa JC
Brain Res; 2005 Jun; 1047(2):148-58. PubMed ID: 15901483
[TBL] [Abstract][Full Text] [Related]
31. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
32. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
Chakraborty A; Guha S
Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
[TBL] [Abstract][Full Text] [Related]
33. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease.
Diguet E; Fernagut PO; Wei X; Du Y; Rouland R; Gross C; Bezard E; Tison F
Eur J Neurosci; 2004 Jun; 19(12):3266-76. PubMed ID: 15217383
[TBL] [Abstract][Full Text] [Related]
34. Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.
Blum D; Gall D; Cuvelier L; Schiffmann SN
Neuroreport; 2001 Jun; 12(8):1769-72. PubMed ID: 11409756
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats.
Kim JH; Kim S; Yoon IS; Lee JH; Jang BJ; Jeong SM; Lee JH; Lee BH; Han JS; Oh S; Kim HC; Park TK; Rhim H; Nah SY
Neuropharmacology; 2005 Apr; 48(5):743-56. PubMed ID: 15814108
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain.
Bizat N; Galas MC; Jacquard C; Boyer F; Hermel JM; Schiffmann SN; Hantraye P; Blum D; Brouillet E
Neuropharmacology; 2005 Oct; 49(5):695-702. PubMed ID: 15998526
[TBL] [Abstract][Full Text] [Related]
37. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
[TBL] [Abstract][Full Text] [Related]
38. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.
Schneider A; Krüger C; Steigleder T; Weber D; Pitzer C; Laage R; Aronowski J; Maurer MH; Gassler N; Mier W; Hasselblatt M; Kollmar R; Schwab S; Sommer C; Bach A; Kuhn HG; Schäbitz WR
J Clin Invest; 2005 Aug; 115(8):2083-98. PubMed ID: 16007267
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease.
Napolitano M; Costa L; Palermo R; Giovenco A; Vacca A; Gulino A
Brain Res Bull; 2011 May; 85(3-4):231-7. PubMed ID: 21440606
[TBL] [Abstract][Full Text] [Related]
40. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
